Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

NCT00142155 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom's Macroglobulinemia

Interventions

DRUG: Rituximab
DRUG: monoclonal antibodies

Sponsor

Dana-Farber Cancer Institute